Eli Lilly profit tops estimates on diabetes drug strength

Eli Lilly and Co reported a higher-than-expected quarterly profit on Thursday, helped by strong demand for its diabetes drug, Trulicity, and psoriasis treatment, Taltz.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news